We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANSCW
251
Agriculture & Natural Solutions Acquisition Corp Warrant
ANSCW
$107K
$3.74K ﹤0.01%
24,950
– –
DISTW
252
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$3.73K ﹤0.01%
31,050
– –
SDAWW
253
SunCar Technology Group Warrant
SDAWW
$3.32K ﹤0.01%
47,400
– –
HSPOW
254
DELISTED
Horizon Space Acquisition I Corp Warrant
HSPOW
$2.71K ﹤0.01%
67,700
– –
SPKLW
255
Spark I Acquisition Corp Warrant
SPKLW
$7M
$2.46K ﹤0.01%
12,650
– –
SLXNW
256
Silexion Therapeutics Warrant
SLXNW
$119K
$1.56K ﹤0.01%
38,150
– –
ALCYW
257
DELISTED
Alchemy Investments Acquisition Corp 1 Warrants
ALCYW
$1.36K ﹤0.01%
12,050
– –
OSRHW
258
OSR Health Warrant
OSRHW
$351K
$1.1K ﹤0.01%
20,800
– –
NUAIW
259
New Era Energy & Digital Inc Warrants
NUAIW
$14.9M
$980 ﹤0.01%
10,550
– –
MSAIW icon
260
MultiSensor AI Holdings Warrant
MSAIW
$751K
$804 ﹤0.01%
24,900
– –
BNZIW
261
DELISTED
Banzai International Warrant
BNZIW
$317 ﹤0.01%
12,711
– –
ZAPPW
262
DELISTED
Zapp Electric Vehicles Group Limited Warrant
ZAPPW
$96 ﹤0.01%
43,850
– –
CLRCW
263
DELISTED
ClimateRock Warrant
CLRCW
$3 ﹤0.01%
34,703
– –
BATL icon
264
Battalion Oil
BATL
$29.9M
– –
-34,150
Closed -$44.4K
CKPT
265
DELISTED
Checkpoint Therapeutics
CKPT
– –
-1,019,750
Closed -$4.12M
DADA
266
DELISTED
Dada Nexus
DADA
– –
-193,350
Closed -$358K
DAN icon
267
Dana Inc
DAN
$3.27B
– –
-78,350
Closed -$1.04M
DESP
268
DELISTED
Despegar.com
DESP
– –
-679,234
Closed -$12.8M
DFS
269
DELISTED
Discover Financial Services
DFS
– –
-97,896
Closed -$16.7M
GAN
270
DELISTED
GAN Ltd
GAN
– –
-489,768
Closed -$867K
HEES
271
DELISTED
H&E Equipment Services
HEES
– –
-98,144
Closed -$9.3M
JWN
272
DELISTED
Nordstrom
JWN
– –
-245,700
Closed -$6.01M
LOPP icon
273
Gabelli Love Our Planet & People ETF
LOPP
$15.5M
– –
-7,800
Closed -$207K
OPTN
274
DELISTED
OptiNose
OPTN
– –
-60,800
Closed -$558K
PLYA
275
DELISTED
Playa Hotels & Resorts
PLYA
– –
-722,300
Closed -$9.63M
9 10
11
12 13

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.